Link to Pubmed [PMID] – 23799048
PLoS ONE 2013;8(6):e65776
The performance of serum biomarkers for the early detection of invasive aspergillosis expectedly depends on the timing of test results relative to the empirical administration of antifungal therapy during neutropenia, although a dynamic evaluation framework is lacking.